- Bloom Health Partners (BLMH) has announced the opening of a new diagnostic testing facility in New Jersey
- The New Jersey facility will serve Fortune 500 clients, sporting events and film/TV productions in New York and surrounding areas
- Bloom Health Partners is a global platform for healthcare security, diagnostic testing, and occupational health-tech
- Bloom Health Partners Inc. (BLMH) opened trading at C$0.365 per share
Bloom Health Partners (BLMH) has announced the opening of a new facility in New Jersey to provide operational health services and diagnostic testing.
The New Jersey facility will serve Fortune 500 clients, sporting events and film/TV productions in New York and surrounding areas. The new facility is in addition to Bloom’s existing locations in Dallas, Atlanta, Montgomery, and Los Angeles.
“Our new location in New Jersey will support operational health services for some of the nation’s largest organizations,” said Andrew Morton, CEO of Bloom.
“We’re focused on occupational health-tech for our clients. However, we continue to see rising demand for testing services due to variants in the ongoing pandemic and testing mandates. With the opening of facilities that cover major centers like New York, we have the ability to meet high-volume testing demands while we scale up our occupational health clients. With locations in key cities, Bloom is well-positioned to support clients across the U.S., both regionally and on a national scale.”
Bloom Health Partners is a global platform for healthcare security, diagnostic testing, and occupational health-tech.
Bloom Health Partners Inc. (BLMH) opened trading at C$0.365 per share.